N. Steckel

发表

No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis.

A. Elmaagacli, D. Beelen, M. Koldehoff, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia

A. Elmaagacli, M. Koldehoff, R. Trenschel, 2004, Bone Marrow Transplantation.

Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation

A. Elmaagacli, M. Koldehoff, R. Trenschel, 2005, Transplant infectious disease : an official journal of the Transplantation Society.

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

C. Craddock, A. Zander, M. Labopin, 2011, Leukemia.

No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors.

Y. Hegerfeldt, A. Elmaagacli, D. Beelen, 2010, Blood.

Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract

J. Kehrmann, T. Liebregts, D. Beelen, 2019, Annals of Hematology.

Growth factor‐independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate

A. Elmaagacli, J. Zakrzewski, D. Beelen, 2007, British journal of haematology.

COVID‐19‐associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates

J. Buer, J. Steinmann, F. Herbstreit, 2022, Mycoses.

Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD

A. Elmaagacli, H. Baba, U. Hillen, 2014, Bone Marrow Transplantation.

Indoleamine 2,3‐Dioxygenase Expression in Patients with Acute Graft‐versus‐Host Disease after Allogeneic Stem Cell Transplantation and in Pregnant Women: Association with the Induction of Allogeneic Immune Tolerance?

D. Beelen, N. Steckel, A. H. Elmaagacli, 2003, Scandinavian journal of immunology.

Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.

P. Horn, K. Fleischhauer, M. Trilling, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease

P. Horn, D. Beelen, V. Rebmann, 2016, International journal of molecular sciences.

Reduced Risk for Molecular Disease in Patients with Chronic Myeloid Leukemia after Transplantation from a KIR-Mismatched Donor

A. Elmaagacli, H. Grosse-wilde, D. Beelen, 2005, Transplantation.

Prevalence of COVID-19 Associated Mucormycosis in a German Tertiary Care Hospital

J. Buer, F. Herbstreit, H. Verhasselt, 2022, Journal of fungi.

Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays

J. Steinmann, T. Liebregts, M. Fiedler, 2018, Biology of Blood and Marrow Transplantation.

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.

S. Schnittger, Y. Hegerfeldt, A. Elmaagacli, 2011, Blood.

Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia

A. Elmaagacli, D. Beelen, M. Koldehoff, 2007, Clinical and Experimental Medicine.

A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase

A. Elmaagacli, S. Seeber, B. Opalka, 2001, Bone Marrow Transplantation.

Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.

A. Elmaagacli, H. Grosse-wilde, D. Beelen, 2003, Blood.

Optimizing anti‐T‐lymphocyte globulin dosing to improve long‐term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies

K. Fleischhauer, T. Liebregts, D. Beelen, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

D. Lazarević, D. Blaise, A. Nagler, 2018, Blood.

Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation

A. Elmaagacli, M. Koldehoff, R. Trenschel, 2007, Bone Marrow Transplantation.

Mutations in Innate Immune System NOD2/CARD 15 and TLR-4 (Thr399Ile) Genes Influence the Risk for Severe Acute Graft-versus-Host Disease in Patients Who Underwent an Allogeneic Transplantation

A. Elmaagacli, R. S. Ross, M. Roggendorf, 2006, Transplantation.

Quantitative analysis of chimerism after allogeneic stem cell transplantation by real‐time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats,and Y‐chromosome‐specific sequences

A. Elmaagacli, D. Beelen, M. Koldehoff, 2006, American journal of hematology.

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis

A. Elmaagacli, D. Beelen, M. Koldehoff, 2012, Haematologica.

High‐dose melphalan‐based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia

G. Lenz, W. Berdel, M. Stelljes, 2018, British journal of haematology.

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.

N. Kröger, T. Luft, U. Germing, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia

A. Elmaagacli, D. Beelen, M. Koldehoff, 2006, Clinical and Experimental Medicine.

Ependymomas: a clinical and pathologic study. Part I. Biologic features.

C. Stiller, J. Hughes, E. Ilgren, 1984, Clinical neuropathology.

Ependymomas: a clinical and pathologic study. Part II. Survival features.

C. Stiller, J. Hughes, E. Ilgren, 1984, Clinical neuropathology.

Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease

B. Adam, T. Liebregts, D. Beelen, 2016, Digestive Diseases and Sciences.

Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients

A. Elmaagacli, D. Beelen, M. Koldehoff, 2006, Clinical transplantation.

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation

A. Elmaagacli, P. Rath, M. Koldehoff, 2005, Bone Marrow Transplantation.